Skip to content

Ziteng Qiu

1 paper in the library · publishing 2025

Papers

Sort Most recent Most cited

Esketamine for Depression: From Therapeutic Characteristics to Efficacy and Safety

MedScien October 23, 2025 Ziteng Qiu

More than 280 million individuals worldwide suffer from depression, which is one of the main causes of mental disability. It has multiple subtypes, and conventional treatments have limitations such as slow onset of action, high non-response rate, and numerous side effects. For instance, it takes two to six weeks for selective serotonin reuptake inhibitors (SSRIs) to start working, and about 30%...